Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Ashley Comer

Nurse Practitioner, Family Charleston, WV Nurse Practitioner

NPI 1306249966 CMS profile 11060650

400 Court St Ste 100, Ste 100, Charleston, WV 25301

Open in the dashboard

General payments

$212,688

1,229 records reported · program years 2021–2025

Research payments

$70

Paid to them · 2 records reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ashley Comer of Charleston, WV is reported in the CMS Open Payments database as having received $212,688 across 1,229 general payments and $70 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29,229 164
2024 General $17,444 177
2023 General $53,838 278
2022 General $93,219 420
2021 General $18,957 190
2021 Research $70 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ashley Comer
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Ashley Comer were reported at $29,229. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Ashley Comer Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $18,957 $124 $35–$379 $132
2022 $93,219 $141 $44–$430 $149
2023 $53,838 $154 $49–$476 $160
2024 $17,444 $165 $51–$504 $164
2025 $29,229 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $127,883 900 payments
  2. Painteq LLC $33,970 83 payments
  3. Saluda Medical Americas, Inc. $21,259 94 payments
  4. Spinal Simplicity, LLC $14,170 58 payments
  5. Vertos Medical, Inc. $8,205 28 payments
  6. SPR Therapeutics, Inc $1,991 9 payments
  7. Nalu Medical, Inc. $1,600 1 payment
  8. Stryker Corporation $1,185 7 payments
  9. Boston Scientific Corporation $903 18 payments
  10. Nevro Corp. $418 6 payments
  11. Other $1,104 25 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $53,313 65 payments
  2. Food and Beverage $51,125 924 payments
  3. Travel and Lodging $43,149 125 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $38,858 72 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,795 34 payments
  6. Education $7,430 8 payments
  7. Entertainment $18 1 payment
Products named General payments · program years 2021–2025
  1. PROCLAIM Neuromodulation $68,504 427 payments
  2. PAINTEQ $33,970 83 payments
  3. PROCLAIM Neuromodulation $19,175 87 payments
  4. HA MINUTEMAN G3-R $14,170 58 payments
  5. Evoke SCS $13,347 40 payments
  6. Proclaim IPG $12,798 154 payments
  7. PROCLAIM Structural Heart $8,304 37 payments
  8. mild Device Kit $8,205 28 payments
  9. Evoke $7,912 54 payments
  10. PROCLAIM Structural Heart $3,837 21 payments
  11. Other $20,803 242 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. Saluda Medical Americas, Inc. $70 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

462

Median for Nurse Practitioner: 389

Drug cost

$16,326

Median for Nurse Practitioner: $21,885

Branded share of claims

19%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Buprenorphine Generic 21 $5,564
Movantik Naloxegol Oxalate Brand 11 $4,356
Gabapentin Generic 115 $1,786
Acetaminophen-Codeine Acetaminophen With Codeine Brand 77 $1,727
Lidocaine Generic 14 $1,071
Tramadol Hcl Generic 122 $593
Tizanidine Hcl Generic 31 $424
Pregabalin Generic 20 $326
Baclofen Generic 11 $170
Duloxetine Hcl Generic 11 $147

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$11,452

Medicare's payments for the services billed

Medicare patients

194

Average age 71

Services billed

261

112 women, 82 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 52%
Diabetes 46%
Ischemic heart disease 44%
Chronic kidney disease 34%
COPD 22%
Atrial fibrillation 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,231 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record